§ 1311.115. Additional requirements for two-factor authentication.
147 words·~1 min read·
/us/cfr/t21/s§ 1311.115·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)To sign a controlled substance prescription, the electronic prescription application must require the practitioner to authenticate to the application using an authentication protocol that uses two of the following three factors:
(1)Something only the practitioner knows, such as a password or response to a challenge question.
(2)Something the practitioner is, biometric data such as a fingerprint or iris scan.
(3)Something the practitioner has, a device (hard token) separate from the computer to which the practitioner is gaining access.
(b)If one factor is a hard token, it must be separate from the computer to which it is gaining access and must meet at least the criteria of FIPS 140-2 Security Level 1, as incorporated by reference in § 1311.08, for cryptographic modules or one-time-password devices.
(c)If one factor is a biometric, the biometric subsystem must comply with the requirements of § 1311.116.
Connections3 cite this
Cited by 3 sections · top 2
Citation graph
cites case law
§ 1311.115
Additional requirements for two-factor authentication.
Fed. Reg.×3
Cites 0Cited by 3 across 1 source